Lilly announces CNS tie-up with UK biotech Evox Therapeutics

Eli Lilly has announced a central nervous system research tie-up with UK biotech Evox Therapeutics, which focuses on drug engineering using vesicles to deliver drugs to targets. 

FDA clears Lilly’s Retevmo for RET-positive lung, thyroid ca...

Eli Lilly now has a second approved drug from its takeover of Loxo Oncology last year after getting the go-ahead from the FDA for RET inhibitor Retevmo.

Lilly raises 2020 earnings forecast on pandemic stockpiling

AZ, Lilly join efforts to develop drugs for COVID-19

Pharma giants including Novartis collaborate on COVID-19 the...

A consortium of life sciences companies including pharma giants such as Novartis and Johnson & Johnson, are to collaborate to develop and manufacture vaccines, diagnostics and treatment

Lilly, Galapagos suspend trials as COVID-19 hits health syst...